Gardasil and Rotarix nods mark further Japanese progress on vaccines
This article was originally published in Scrip
Executive Summary
MSD's (Merck & Co) cervical cancer vaccine Gardasil has been recommended for approval in Japan, moving it a step closer to an important market where GlaxoSmithKline's competing product Cervarix was approved in October 2009.